SEC Tracker
Get the app

Cingulate CING

Cingulate announces FDA CRL for CTx-1301

Cingulate (CING) filed an 8-K with the SEC on Nov 10, 2026, 8:10 am ET. Source: the filing on SEC EDGAR.

Item 7.01 Investor disclosure, Item 8.01 Other events

Form
8-K
Filed
Importance
Notable
  1. Received CRL from FDA in June 2026
  2. CMC requests identified in CRL
  3. Resubmission expected between December 2026 and January 2027
  4. Potential commercial launch in Q3 2027

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when Cingulate files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.